 Propylamines
"Propylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D011437
|
| MeSH Number(s) |
D02.092.831
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propylamines".
Below are MeSH descriptors whose meaning is more specific than "Propylamines".
This graph shows the total number of publications written about "Propylamines" by people in this website by year, and whether "Propylamines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1986 | 1 | 0 | 1 | | 1993 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2012 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Propylamines" by people in Profiles.
-
Stavitskaya L, Seminerio MJ, Healy JR, Noorbakhsh B, Matsumoto RR, Coop A. Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors. Bioorg Med Chem. 2013 Sep 01; 21(17):4923-7.
-
Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC. Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv. 2013 Apr 01; 64(4):339-46.
-
Garfield CF, Dorsey ER, Zhu S, Huskamp HA, Conti R, Dusetzina SB, Higashi A, Perrin JM, Kornfield R, Alexander GC. Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012 Mar-Apr; 12(2):110-6.
-
Robson MJ, Elliott M, Seminerio MJ, Matsumoto RR. Evaluation of sigma (s) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. Eur Neuropsychopharmacol. 2012 Apr; 22(4):308-17.
-
Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry. 2009 Apr 01; 65(7):550-5.
-
Chong AS, Markham PN, Gebel HM, Bines SD, Coon JS. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother. 1993; 36(2):133-9.
-
Alamercery Y, Wilkins P, Karrison T. Functional equality of coordinating centers in a multicenter clinical trial. Experience of the International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT). Control Clin Trials. 1986 Mar; 7(1):38-52.
-
Souter RW, Dinner A. GLC determination of degradation of two related amine uptake inhibitors. J Pharm Sci. 1976 Mar; 65(3):457-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|